Kevin Harris

Kevin Harris, MD

Director of the Aortic Dissection Program

Dr. Harris moved from Washington University School of Medicine to his current position at Minneapolis Heart Institute® in 1998. He is a clinical cardiologist and echocardiographer with clinical and research interests in aortic disease and aortic dissection, valvular heart disease, hypertrophic cardiomyopathy and heart disease in athletes.

He is actively involved in cardiology education, serving as associate program director for cardiology training for the HCMC/Minneapolis Heart Institute® at Abbott Northwestern Hospital training program. Prior to this role, he was a member of the University of Minnesota fellowship committee for 12 years. Dr. Harris is also the current director of the Aortic Dissection Program and serves as a member of the International Registry of Acute Aortic Dissection (IRAD) group, having authored over 100 manuscripts.

In 2024, Dr. Harris joined MHIF's board of directors, feeling grateful for the support he'd been given over the years. Since it's inception, he's been closely involved in the MHIF clinical research internship program and has enjoyed mentoring several interns, noting how gratifying it is to see research come to completion and witness the career trajectory of the interns. 

"Investigator-initiated research which would not be possible without the direct support of the foundation and my colleagues. I'm grateful for opportunities to participate in the educational mission of MHIF, both with healthcare professionals and the community at large." - Dr. Kevin Harris

Back to Board of Directors Back to Valve Team

Kevin Harris
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.